Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2003 June;45(2) > Panminerva Medica 2003 June;45(2):151-4

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

ORIGINAL ARTICLES  


Panminerva Medica 2003 June;45(2):151-4

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Pathophysiology of endothelin and medical emergencies

Bruno C. M., Neri S., Di Prima P., Sciacca C.

Department of Internal Medicine and Systemic Diseases, University of Catania, Catania, Italy


PDF  


Pathophysiology of endo­the­lin-1, a vas­o­con­stric­tor and a mit­o­gen­ic pep­tide, has ­been exten­sive­ly inves­ti­gat­ed in ­recent ­years. The ­authors ­have exam­ined the ­main clin­i­cal and experi­men­tal evi­denc­e regard­ing the involve­ment of ­this pep­tide in ­some med­i­cal emer­gen­cies, name­ly myo­car­dial infarc­tion, ­stroke and hepa­to-­renal syn­drome. Literature ­data sug­gest an emerg­ing path­o­phy­sio­log­i­cal ­role for endo­the­lin in ­such clin­i­cal con­di­tions.

top of page

Publication History

Cite this article as

Corresponding author e-mail